Rani Therapeutics Holdings Class ARANI
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 34 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings, down 3 from Q1 2024. 3 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($2.7M), Nan Fung Group Holdings Ltd ($1.9M) and Alphabet Inc. ($1.7M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Rani Therapeutics Holdings Class A
- CUSIP
- 753018100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $124K |
| Exits | 5 | $236K |
All 13F filers, Q1 2024 → Q2 2024: 135,097 shares bought and 480,445 shares sold, net −345,348 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Vanguard Group Inc. | 0.00% | Add +3.6% | 709,828 | $2.7M |
| Nan Fung Group Holdings Ltd | 2.00% | No change | 493,584 | $1.9M |
| Alphabet Inc. | 0.09% | No change | 448,492 | $1.7M |
| United Services Automobile Association | 0.03% | Reduce -35.2% | 312,095 | $1.2M |
| Takeda Pharmaceutical Co. Ltd. | 0.35% | Reduce -36.5% | 215,172 | $818K |
| Geode Capital Management, LLC | 0.00% | Add +15.2% | 150,734 | $573K |
| Stifel Financial Corp. | 0.00% | Add +1.6% | 134,620 | $512K |
| Bank of America Corp. | 0.00% | Reduce -26.2% | 91,846 | $349K |
| Bridgeway Capital Management, LLC | 0.01% | Add +38.8% | 71,500 | $272K |
| BlackRock Inc. | 0.00% | No change | 63,583 | $242K |
| Lasry Marc | 0.24% | No change | 62,887 | $239K |
| King Luther Capital Management Corp. | 0.00% | No change | 56,129 | $213K |
| Motco | 0.01% | No change | 48,129 | $183K |
| State Street Corp. | 0.00% | Add +24.6% | 42,042 | $160K |
| Northern Trust Corp. | 0.00% | Add +35.9% | 35,306 | $134K |
| Brown Advisory Inc. | 0.00% | Reduce -3.0% | 32,911 | $125K |
| Renaissance Technologies | 0.00% | Reduce -69.1% | 21,700 | $82K |
| Marshall Wace, LLP | 0.00% | New | 21,247 | $81K |
| Lafayette Investments, Inc. | 0.02% | No change | 19,893 | $76K |
| Citadel Advisors | 0.00% | Add +47.2% | 14,765 | $56K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1065.2% | 14,437 | $55K |
| Prime Capital Investment Advisors, LLC | 0.00% | No change | 13,882 | $53K |
| Virtu Financial LLC | 0.00% | New | 10,153 | $39K |
| Islay Capital Management, LLC | 0.03% | No change | 9,611 | $37K |
| UBS Group AG | 0.00% | No change | 3,000 | $11K |
| Morgan Stanley | 0.00% | Add +20.4% | 2,951 | $11K |
| Allworth Financial LP | 0.00% | No change | 3,119 | $10K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -78.1% | 2,000 | $8K |
| Simplex Trading, LLC | 0.00% | Add +8.7% | 1,482 | $5K |
| Belvedere Trading LLC | 0.00% | New | 991 | $4K |
| Rhumbline Advisers | 0.00% | No change | 312 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.4% | 71 | $270 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $12 |
| Royal Bank of Canada | 0.00% | No change | 12 | $0 |
"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.